HIV 1 News and Research

RSS

AHF’s Magic Johnson ‘Testing America’ Tour arrives in Nashville to offer free HIV testing

AHF’s Magic Johnson ‘Testing America’ Tour, a six month, 48 state national cross country HIV testing tour, arrives in Nashville, Tennessee and will offer free HIV testing, along with local partner Street Works at events today and tomorrow.

17 Mar 2010

Systemic underfunding of CDC's Division of Viral Hepatitis puts millions of Americans' health at risk

Warning that "systemic underfunding of the Centers for Disease Control's Division of Viral Hepatitis puts millions of Americans' health and well-being at risk," the National Viral Hepatitis Roundtable today called on the Administration to work with Congress to take decisive action this year to fix the funding failure for viral hepatitis screening, surveillance, and early intervention programs.

17 Mar 2010

Can preventative vaccines curb the rising numbers of HIV cases?

According to a recent United Nations study, HIV infection rates among high-risk groups such as gays, drug users and sex workers are on the rise around the world.

17 Mar 2010

Restoring immune function in HIV patients: Therapies targeting PD-1 and IL-10 molecules needed

New research conducted by the scientific director for VGTI Florida and his colleagues at the University of Montreal, in collaboration with scientists from the NIH and the McGill University Hospital center, may soon lead to an expansion of the drug arsenal used to fight HIV. The research sheds new light on how HIV gradually weakens the body’s immune system and highlights the need for new research into therapies that will target the chain of events that cause the progression of the disease.

17 Mar 2010

Pathway Genomics' personal Genetic Health Report now available

Pathway Genomics Inc., a U.S. based genetic testing company, announced the immediate availability of its personal Genetic Health Report. This customized and innovative personal genetic health report contains information on more than 70 health conditions, including pharmacogenetics (prescription medication response), propensity for complex disease, and carrier status (pre-pregnancy health).

17 Mar 2010

AIDS activists set to rally at South Carolina State House to reinstate all $5.9M in HIV/AIDS funding

A coalition of hundreds of AIDS activists, patients, medical care providers and concerned citizens of all backgrounds are expected to gather tomorrow, Wednesday, March 17th at 12:30 pm on the north side of the South Carolina State House for a rally to reinstate all $5.9 million in HIV/AIDS funding.

17 Mar 2010

Sidibe calls for a 'prevention revolution' to fight HIV/AIDS

UNAIDS head Michel Sidibe on Monday called for a "prevention revolution" to fight HIV/AIDS and addressed laws he says make high-risk groups more vulnerable to the disease, the Associated Press reports. Speaking to a group of journalists in New York, Sidibe "said 'it is unacceptable' that 85 countries still have laws criminalizing same sex relations among adults, including seven that impose the death penalty for homosexual practices," the news service writes.

17 Mar 2010

Antidepressants effective against depression in patients suffering from physical illnesses

Antidepressants are effective against depression in patients suffering from physical illnesses, according to a new systematic review by Cochrane researchers at King's Health Partners Academic Health Sciences Centre in the UK. The researchers found the drugs were more effective than placebos at treating depression in these patients.

17 Mar 2010

EU-India free-trade negotiations could limit access to affordable, generic drugs, advocacy group says

The advocacy group Medecins Sans Frontieres (MSF) recently warned that free-trade negotiations between the EU and India could limit access to "affordable generic drugs" for people in India and the rest of the developing world, Reuters reports.

17 Mar 2010

Cytheris study: rhIL-7 treatment restores T cell trafficking and improves survival in animal model of sepsis

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced publication of data from a preclinical study in a clinically relevant animal model of sepsis showing that recombinant human Interleukin-7 (rhIL-7) treatment not only restores T cell trafficking and function, but also translates into improved survival.

16 Mar 2010

MRSA Survivors Network urges CDC to declare MRSA an epidemic

MRSA Survivors Network, the nonprofit organization, along with other advocates, urgently plead with the CDC – (Centers for Disease Control and Prevention), along with the Department of Health and Human Services (DHHS) to finally acknowledge the public health crisis to the public and take action.

16 Mar 2010

Banana lectin discovery may lead to potential new treatments for preventing sexual transmission of HIV

A potent new inhibitor of HIV, derived from bananas, may open the door to new treatments to prevent sexual transmission of HIV, according to a University of Michigan Medical School study published this week.

16 Mar 2010

Opinions: Discrimination against sexual orientation; WFP in Somalia; Haiti's recovery; WHO's policy role

In a Washington Post opinion piece, Desmond Tutu, archbishop emeritus of Cape Town, South Africa, and Nobel Peace Prize recipient, speaks out against efforts to deny individuals "their fundamental rights and freedoms" based on their sexual orientation.

16 Mar 2010

Clinton delivers speech at U.N. women's meeting as conference closes

"Calling the subjugation of women a threat to American security, U.S. Secretary of State Hillary [Rodham] Clinton made a vibrant plea to give equal rights to women around the world," during a speech a the U.N. on Friday, Agence France-Presse reports.

16 Mar 2010

Experts discuss PEPFAR funding in congressional hearing

At a recent hearing of the House Subcommittee on Africa and Global Health, "[i]nternational health organisations working to help check the spread of AIDS in Africa said meagre increases in funds from the U.S. government this year would be a step backwards. Some experts also emphasised that prevention must get appropriate attention in any fight against the disease," Inter Press Service reports.

15 Mar 2010

StockPreacher.com announces investment report featuring GenVec

StockPreacher.com announces an investment report featuring GenVec Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

15 Mar 2010

New PEGylated Polylysine dendrimers: Benefits patients with cancer, HIV and lymphatic conditions

Monash Institute of Pharmaceutical Science researchers, in collaboration with the biotechnology company Starpharma Holdings Ltd have developed a new method to deliver medications that may benefit thousands of patients with particular types of cancer, HIV and lymphatic conditions world-wide.

15 Mar 2010

Ardea Biosciences' revenues total $8.3M for three months ended December 31, 2009

Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.

12 Mar 2010

Achillion Pharmaceuticals reports net loss of $6.7M for three months ended December 31, 2009

Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported financial results for the three and twelve months ended December 31, 2009.

12 Mar 2010

New MMMCC center improves patients’ access to medical marijuana

Marijuana is not just for brownies anymore. It has touched the lives of thousands of Michigan residents who are struggling with chronic pain, severe nausea, seizures, spasms or wasting syndrome.

12 Mar 2010

HIV 1 News and Research

AHF’s Magic Johnson ‘Testing America’ Tour arrives in Nashville to offer free HIV testing

Systemic underfunding of CDC's Division of Viral Hepatitis puts millions of Americans' health at risk

Can preventative vaccines curb the rising numbers of HIV cases?

Restoring immune function in HIV patients: Therapies targeting PD-1 and IL-10 molecules needed

Pathway Genomics' personal Genetic Health Report now available

AIDS activists set to rally at South Carolina State House to reinstate all $5.9M in HIV/AIDS funding

Sidibe calls for a 'prevention revolution' to fight HIV/AIDS

Antidepressants effective against depression in patients suffering from physical illnesses

EU-India free-trade negotiations could limit access to affordable, generic drugs, advocacy group says

Cytheris study: rhIL-7 treatment restores T cell trafficking and improves survival in animal model of sepsis

MRSA Survivors Network urges CDC to declare MRSA an epidemic

Banana lectin discovery may lead to potential new treatments for preventing sexual transmission of HIV

Opinions: Discrimination against sexual orientation; WFP in Somalia; Haiti's recovery; WHO's policy role

Clinton delivers speech at U.N. women's meeting as conference closes

Experts discuss PEPFAR funding in congressional hearing

StockPreacher.com announces investment report featuring GenVec

New PEGylated Polylysine dendrimers: Benefits patients with cancer, HIV and lymphatic conditions

Ardea Biosciences' revenues total $8.3M for three months ended December 31, 2009

Achillion Pharmaceuticals reports net loss of $6.7M for three months ended December 31, 2009

New MMMCC center improves patients’ access to medical marijuana

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News